Company Filing History:
Years Active: 2008
Title: Nils Holler: Innovator in Recombinant Fusion Proteins
Introduction
Nils Holler is a notable inventor based in Radelfingen, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant fusion proteins. His innovative work has led to the creation of a unique patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Nils Holler holds a patent for a product known as Bimer, which is an oligomer of a dimer, trimer, quadromer, or pentamer of recombinant fusion proteins. This invention relates to oligomers characterized by recombinant fusion proteins that contain at least one component A and one component B. Component A includes a protein or protein segment with biological functions, while component B is responsible for dimerizing or oligomerizing the fusion proteins without the involvement of third-party molecules. The patent also discusses the use of these oligomers in producing medicaments, as well as the associated DNA sequences and expression vectors.
Career Highlights
Throughout his career, Nils Holler has demonstrated a strong commitment to research and development in the biotechnology sector. His work at Apotech Research and Development Ltd. has positioned him as a key player in the field. His innovative approach to recombinant fusion proteins has the potential to impact various medical applications significantly.
Collaborations
Nils has collaborated with esteemed colleagues such as Jürg Tschopp and Pascal Schneider. These partnerships have further enriched his research and contributed to the advancement of his projects.
Conclusion
Nils Holler is a distinguished inventor whose work in recombinant fusion proteins exemplifies innovation in biotechnology. His patent for Bimer highlights his contributions to medical science and showcases the potential for future advancements in the field.